Minimal clinically important differences in Incontinence Quality-of-Life scores in stress urinary incontinence
Authors:
- Ilker YalcinIYIlker Yalcin
- Donald L. PatrickDPDonald L. Patrick
- Kent SummersKSKent Summers
- Kraig KinchenKKKraig Kinchen
- Richard C. BumpRBRichard C. Bump
Abstract
No abstract availableKeywords
Funding Information
- Eli Lilly and Company
- Boehringer Ingelheim
This publication has 20 references indexed in Scilit:
- Pharmacological Treatment of Women Awaiting Surgery for Stress Urinary IncontinenceObstetrics & Gynecology, 2004
- Duloxetine vs placebo in the treatment of stress urinary incontinence: a four‐continent randomized clinical trialBJU International, 2004
- Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinenceBJOG: An International Journal of Obstetrics & Gynaecology, 2004
- Duloxetine Versus Placebo for the Treatment of North American Women With Stress Urinary IncontinenceJournal of Urology, 2003
- Duloxetine versus placebo in the treatment of stress urinary incontinenceAmerican Journal of Obstetrics and Gynecology, 2002
- Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL)Urology, 1999
- Outcome measures for research in adult women with symptoms of lower urinary tract dysfunctionNeurourology and Urodynamics, 1998
- Evaluating the outcome of surgery for pelvic organ prolapseAmerican Journal of Obstetrics and Gynecology, 1998
- Standardization of outcome studies in patients with lower urinary tract dysfunction: A report on general principles from the standardisation committee of the international continence societyNeurourology and Urodynamics, 1998
- Quality of life of persons with urinary incontinence: Development of a new measureUrology, 1996